Inventor
JOHE KARL K
US25 patents
⚠️ This page may combine multiple inventors who share the name “JOHE KARL K”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NEURALSTEM INC
15 patentsUS7560553B1Jul 14, 2009
Use of fuse nicotinamides to promote neurogenesis
NEURALSTEM INC27 citations95
US8362262B2Jan 29, 2013
Compositions to effect neuronal growth
NEURALSTEM INC11 citations92
US7691629B2Apr 6, 2010
Transplantation of human neural cells for treatment of neurodegenerative conditions
NEURALSTEM INC22 citations91
US10413534B2Sep 17, 2019
Amelioration of certain deficiencies due to stroke
NEURALSTEM INC3 citations73
US9572807B2Feb 21, 2017
Protocols for treatment of major depressive disorder (MDD)
NEURALSTEM INC6 citations73
US8030492B2Oct 4, 2011
Compositions to effect neuronal growth
NEURALSTEM INC5 citations73
US7858628B2Dec 28, 2010
Use of fused nicotinamides to promote neurogenesis
NEURALSTEM INC6 citations73
US9220730B2Dec 29, 2015
Methods of treating ischemic spasticity
NEURALSTEM INC3 citations71
US8846914B2Sep 30, 2014
Compositions to effect neuronal growth
NEURALSTEM INC1 citations62
US8674098B2Mar 18, 2014
Compositions to effect neuronal growth
NEURALSTEM INC1 citations62
US9744194B2Aug 29, 2017
Methods of treating ischemic spasticity
NEURALSTEM INC1 citations60
US10322115B2Jun 18, 2019
Amelioration of neural deficits associated with diabetes
NEURALSTEM INC0 citations52
US10702555B2Jul 7, 2020
Stable neural stem cells comprising an exogenous polynucleotide coding for a growth factor and methods of use thereof
NEURALSTEM INC0 citations51
US9750769B2Sep 5, 2017
Stable neural stem cells comprising an exogenous polynucleotide coding for a growth factor and methods of use thereof
NEURALSTEM INC1 citations51
US10286010B2May 14, 2019
Methods of treating neurodegenerative conditions
NEURALSTEM INC0 citations49
NEURALSTEM BIOPHARMACEUTICALS
3 patentsUS6040180AMar 21, 2000
In vitro generation of differentiated neurons from cultures of mammalian multipotential CNS stem cells
NEURALSTEM BIOPHARMACEUTICALS288 citations98
US6284539B1Sep 4, 2001
Method for generating dopaminergic cells derived from neural precursors
NEURALSTEM BIOPHARMACEUTICALS74 citations95
US7544511B2Jun 9, 2009
Stable neural stem cell line methods
NEURALSTEM BIOPHARMACEUTICALS14 citations78